Henderson Jane

Chief Financial OfficerApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed Jan 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$609K
Net Open-Market Flow
-$609K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 6, 2026Sell(S)2K$80.00$160K185K
Jan 2, 2026Sell(S)4K$75.20$307K187K
Jan 2, 2026Sell(S)2K$74.13$142K191K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 2, 2026Grant(A)84K$084K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-001483) within minutes of acceptance. Every field above traces to the original document. Verify it directly: